Robert Carlson is a principal at Biodesic, a biological engineering, consulting, and design firm in Seattle. He earned a doctorate in physics from Princeton University and is interested in the future role of biology as a human technology. He is the author of Biology Is Technology: The Promise, Peril, and Inevitability of Engineering Life, to be published in late 2009.
The majority of biotech products that have reached the market are the result of just a handful of genetic modifications and insertions. The commercial significance of the biotech sector will grow as its ability to engineer new biological systems expands.
Send an e-mail to let us know how we can make our site better.